Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Torbic

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Journal of Pharmacy Practice|March 27, 2019
Management of Pulmonary Arterial Hypertension in the ICUHeather Torbic
Journal of Pharmacy Practice|February 11, 2015
Evaluation of Inhaled Dornase Alfa Administration in Non-Cystic Fibrosis Patients at a Tertiary Academic Medical CenterHeather Torbic, Gaspar Hacobian
Journal of Critical Care|November 7, 2018
Neuromuscular blocking agents for acute respiratory distress syndromeHeather Torbic, Abhijit Duggal
JAMA|July 21, 2018
Prophylactic Haloperidol for Critically Ill AdultsHeather Torbic, Abhijit Duggal
Pharmacotherapy|February 15, 2018
Antipsychotics, Delirium, and Acute Respiratory Distress Syndrome: What Is the Link?Heather Torbic, Abhijit Duggal
Respiratory Medicine|October 8, 2025
Navigating options for inhaled treprostinil therapy in pulmonary hypertensionHeather Torbic, Adriano R Tonelli
Journal of Cardiovascular Pharmacology and Therapeutics|February 16, 2024
Sotatercept for Pulmonary Arterial Hypertension in the Inpatient SettingHeather Torbic, Adriano R Tonelli
Critical Care (London, England)|September 8, 2019
Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?Heather Torbic, Sudhir Krishnan, Abhijit Duggal
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 20, 2020
Utilizing a Web-based medication tracking system to evaluate emergent medication turnaround timeHeather Torbic, Leticia Vargas, Alyssa Chen
Respiratory Care|May 1, 2021
Neuromuscular Blocking Agents for ARDS: Incentive for Personalized MedicineHeather Torbic, Sudhir Krishnan, Abhijit Duggal
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Journal of Pharmacy Practice|March 27, 2019
Management of Pulmonary Arterial Hypertension in the ICUHeather Torbic
Journal of Pharmacy Practice|February 11, 2015
Evaluation of Inhaled Dornase Alfa Administration in Non-Cystic Fibrosis Patients at a Tertiary Academic Medical CenterHeather Torbic, Gaspar Hacobian
Journal of Critical Care|November 7, 2018
Neuromuscular blocking agents for acute respiratory distress syndromeHeather Torbic, Abhijit Duggal
JAMA|July 21, 2018
Prophylactic Haloperidol for Critically Ill AdultsHeather Torbic, Abhijit Duggal
Pharmacotherapy|February 15, 2018
Antipsychotics, Delirium, and Acute Respiratory Distress Syndrome: What Is the Link?Heather Torbic, Abhijit Duggal
Respiratory Medicine|October 8, 2025
Navigating options for inhaled treprostinil therapy in pulmonary hypertensionHeather Torbic, Adriano R Tonelli
Journal of Cardiovascular Pharmacology and Therapeutics|February 16, 2024
Sotatercept for Pulmonary Arterial Hypertension in the Inpatient SettingHeather Torbic, Adriano R Tonelli
Critical Care (London, England)|September 8, 2019
Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?Heather Torbic, Sudhir Krishnan, Abhijit Duggal
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 20, 2020
Utilizing a Web-based medication tracking system to evaluate emergent medication turnaround timeHeather Torbic, Leticia Vargas, Alyssa Chen
Respiratory Care|May 1, 2021
Neuromuscular Blocking Agents for ARDS: Incentive for Personalized MedicineHeather Torbic, Sudhir Krishnan, Abhijit Duggal
Pageof 6